Stock Scorecard
Stock Summary for Artivion Inc (AORT) - $42.95 as of 8/15/2025 10:03:55 AM EST
Total Score
5 out of 30
Safety Score
47 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for AORT
Positive Quarterly and Annual earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the Annual earnings growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for AORT
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for AORT
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for AORT
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for AORT (47 out of 100)
Stock Price Rating (Max of 10) | 8 |
Historical Stock Price Rating (Max of 10) | 7 |
Stock Price Trend (Max of 10) | 10 |
Book Value (Max of 10) | 4 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 4 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 3 |
Trading Volume (Max of 10) | 6 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for AORT
Financial Details for AORT
Company Overview |
|
---|---|
Ticker | AORT |
Company Name | Artivion Inc |
Country | USA |
Description | Artivion Inc. manufactures, processes and distributes implantable human tissues and medical devices worldwide. |
Sector Name | LIFE SCIENCES |
Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Most Recent Quarter | 6/30/2025 |
Next Earnings Date | 10/30/2025 |
Stock Price History |
|
Last Day Price | 42.95 |
Price 4 Years Ago | 20.35 |
Last Day Price Updated | 8/15/2025 10:03:55 AM EST |
Last Day Volume | 560,218 |
Average Daily Volume | 466,299 |
52-Week High | 43.97 |
52-Week Low | 21.97 |
Last Price to 52 Week Low | 95.49% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 40.86 |
Sector PE | 58.94 |
5-Year Average PE | -0.67 |
Free Cash Flow Ratio | 38.01 |
Industry Free Cash Flow Ratio | 40.94 |
Sector Free Cash Flow Ratio | 30.80 |
Current Ratio Most Recent Quarter | 4.78 |
Total Cash Per Share | 1.13 |
Book Value Per Share Most Recent Quarter | 8.91 |
Price to Book Ratio | 4.91 |
Industry Price to Book Ratio | 4.90 |
Sector Price to Book Ratio | 27.60 |
Price to Sales Ratio Twelve Trailing Months | 5.09 |
Industry Price to Sales Ratio Twelve Trailing Months | 4.12 |
Sector Price to Sales Ratio Twelve Trailing Months | 32.11 |
Analyst Buy Ratings | 5 |
Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
Total Shares Outstanding | 47,183,700 |
Market Capitalization | 2,026,539,915 |
Institutional Ownership | 88.13% |
Dividends |
|
Ex-Dividend Date | 12/9/2015 |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.0300 |
Total Years Dividend Increasing | 4 |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.15 |
Forward Annual Dividend Yield | 0.52% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 1.06% |
5-Year Dividend Growth Rate Percentage | 24.47% |
All-Time Dividend Growth Rate Percentage | 33.89% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | 56.47% |
Reported EPS 12 Trailing Months | -0.43 |
Reported EPS Past Year | 0.23 |
Reported EPS Prior Year | -0.43 |
Net Income Twelve Trailing Months | -17,931,000 |
Net Income Past Year | -13,359,000 |
Net Income Prior Year | -30,690,000 |
Quarterly Revenue Growth YOY | 15.30% |
5-Year Revenue Growth | 7.06% |
Operating Margin Twelve Trailing Months | 9.72% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 53,476,000 |
Total Cash Past Year | 53,463,000 |
Total Cash Prior Year | 58,940,000 |
Net Cash Position Most Recent Quarter | -162,062,000 |
Net Cash Position Past Year | -260,689,000 |
Long Term Debt Past Year | 314,152,000 |
Long Term Debt Prior Year | 305,531,000 |
Total Debt Most Recent Quarter | 215,538,000 |
Equity to Debt Ratio Past Year | 0.47 |
Equity to Debt Ratio Most Recent Quarter | 0.66 |
Total Stockholder Equity Past Year | 276,200,000 |
Total Stockholder Equity Prior Year | 281,780,000 |
Total Stockholder Equity Most Recent Quarter | 419,902,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | 6,592,000 |
Free Cash Flow Per Share Twelve Trailing Months | 0.14 |
Free Cash Flow Past Year | 11,048,000 |
Free Cash Flow Prior Year | 11,395,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | None |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 2.95 |
MACD Signal | 1.64 |
20-Day Bollinger Lower Band | 19.34 |
20-Day Bollinger Middle Band | 29.54 |
20-Day Bollinger Upper Band | 39.75 |
Beta | 1.64 |
RSI | 89.62 |
50-Day SMA | 27.98 |
150-Day SMA | 20.58 |
200-Day SMA | 20.34 |
System |
|
Modified | 8/14/2025 5:27:50 PM EST |